IRB Barcelona synthesizes molecules with anti-tumor potential


The medical portal ""El Médico Hospitaliario" and other media report on IRB Barcelona's research on compounds able to act against EGF, a little-explored cancer target.
The study has been published in ChemBioChem.

Link to La Vanguardia

Link to Jano.es

Link to Medical News Today

Link to Agencia SINC